"Alkaline Phosphatase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
Descriptor ID |
D000469
|
MeSH Number(s) |
D08.811.277.352.650.035
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Alkaline Phosphatase".
Below are MeSH descriptors whose meaning is more specific than "Alkaline Phosphatase".
This graph shows the total number of publications written about "Alkaline Phosphatase" by people in this website by year, and whether "Alkaline Phosphatase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 2 | 2 |
2006 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2011 | 0 | 2 | 2 |
2013 | 1 | 1 | 2 |
2014 | 0 | 1 | 1 |
2015 | 0 | 2 | 2 |
2016 | 1 | 1 | 2 |
2017 | 7 | 19 | 26 |
2018 | 5 | 11 | 16 |
2019 | 0 | 5 | 5 |
2020 | 0 | 4 | 4 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Alkaline Phosphatase" by people in Profiles.
-
The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities. Eur J Gastroenterol Hepatol. 2021 12 01; 33(1S Suppl 1):e274-e281.
-
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol. 2021 07 01; 116(7):1414-1425.
-
COVID-19 and liver injury: a meta-analysis. Eur J Gastroenterol Hepatol. 2021 07 01; 33(7):990-995.
-
Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity. Sci Rep. 2021 05 13; 11(1):10308.
-
Cholestatic liver injury in COVID-19 is a rare and distinct entity and is associated with increased mortality. J Intern Med. 2021 Aug; 290(2):470-472.
-
Evaluation of hepatic enzymes activities in COVID-19 patients. Int Immunopharmacol. 2021 Aug; 97:107701.
-
Effects of a Serum Heating Procedure for Inactivating COVID-19 on Common Biochemical Tests. Clin Lab. 2021 Feb 01; 67(2).
-
Clinical and biochemical indicators of disease severity and neurological findings in COVID-19: A study of King Edward Medical University (KEMU), Pakistan. Pak J Pharm Sci. 2021 Jan; 34(1(Supplementary)):275-281.
-
Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes. J Med Virol. 2021 04; 93(4):2365-2373.
-
Transient benign hyperphosphatasemia due to COVID-19: the first case report. J Pediatr Endocrinol Metab. 2021 Mar 26; 34(3):385-387.